Maraviroc Switch Renal Substudy

• Research type

  Research Study

• Full title

  Maraviroc Switch Renal Substudy: a substudy of MARCH, a randomised, open-label study to evaluate the efficacy and safety of maraviroc (MVC) as a switch for either nucleoside or nucleotide analogue reverse transcriptase inhibitors (N(t)RTI) or boosted protease inhibitors (PI/r) in HIV-1 infected individuals with stable, well-controlled plasma HIV-RNA while taking their first(N(t)RTI) + PI/r regimen of combination antiretroviral therapy (cART).

• IRAS ID

  119052

• Contact name

  Amanda Clarke

• Contact email

  Amanda.clarke@bsuh.nhs.uk

• Sponsor organisation

  University of New South Wales

• REC name

  London - Brighton & Sussex Research Ethics Committee

• REC reference

  12/LO/1954

• Date of REC Opinion

  31 Jan 2013

• REC opinion

  Further Information Favourable Opinion